9 Recruiting Ovarian Cancer Clinical Trials in Boston
Explore active ovarian cancer research studies enrolling participants across Massachusetts near Boston. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Recruiting Ovarian Cancer Studies
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
NeoVax With Nivolumab in Patients With Ovarian Cancer
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
📍 Research Site — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer
📍 Beth Israel Deaconess Medical Center (BIDMC) — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of Isoquercetin in People With Ovarian Cancer
📍 Beth Israel Deaconess Medical Center (Data Collection Only) — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Observational / Diagnostic 🧠 Behavioral & Psychological Program
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Observational / Diagnostic 📋 Clinical Research Protocol
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Observational / Diagnostic 📋 Clinical Research Protocol
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔